blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3459567

EP3459567 - TUMOR CELL-SPECIFIC RESPONSIVE SELF-ASSEMBLING DRUG NANOCONJUGATE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.07.2021
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  21.08.2020
FormerGrant of patent is intended
Status updated on  05.04.2020
FormerExamination is in progress
Status updated on  28.09.2019
FormerRequest for examination was made
Status updated on  22.02.2019
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Korea Institute of Science and Technology
5 Hwarang-ro 14-gil
Seongbuk-gu
Seoul 02792 / KR
[2019/13]
Inventor(s)01 / KIM, Kwangmeyung
5, Hwarang-ro 14 gil
Seongbuk-gu 02792 Seoul / KR
02 / KWON, Ick Chan
5, Hwarang-ro 14 gil
Seongbuk-gu 02792 Seoul / KR
03 / PARK, Juho
5, Hwarang-ro 14 gil
Seongbuk-gu 02792 Seoul / KR
 [2020/39]
Former [2019/13]01 / KIM, Kwangmeyung
5, Hwarang-ro 14 gil, Seongbuk-gu
02792 Seoul / KR
02 / KWON, Ick Chan
5, Hwarang-ro 14 gil, Seongbuk-gu
02792 Seoul / KR
03 / PARK, Juho
5, Hwarang-ro 14 gil, Seongbuk-gu
02792 Seoul / KR
Representative(s)advotec.
Patent- und Rechtsanwaltspartnerschaft
Tappe mbB
Widenmayerstraße 4
80538 München / DE
[N/P]
Former [2019/13]advotec.
Patent- und Rechtsanwälte
Widenmayerstrasse 4
80538 München / DE
Application number, filing date18164779.328.03.2018
[2019/13]
Priority number, dateKR2017012116920.09.2017         Original published format: KR 20170121169
[2019/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3459567
Date:27.03.2019
Language:EN
[2019/13]
Type: B1 Patent specification 
No.:EP3459567
Date:23.09.2020
Language:EN
[2020/39]
Search report(s)(Supplementary) European search report - dispatched on:EP17.10.2018
ClassificationIPC:A61K47/65, A61K47/69, A61K31/704, A61P35/00
[2020/18]
CPC:
A61K31/704 (EP,CN,KR,US); A61K47/67 (KR); A61K47/6931 (CN);
A61K47/64 (KR,US); A23L33/10 (KR); A61K45/00 (CN);
A61K47/65 (EP,US); A61K47/6929 (EP,CN,KR,US); A61K9/51 (US);
A61P35/00 (EP,CN); A23V2002/00 (KR); A23V2200/25 (KR);
A23V2200/308 (KR) (-)
Former IPC [2019/13]A61K47/65, A61K47/69
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/24]
Former [2019/13]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:TUMORZELLSPEZIFISCH REAGIERENDES SELBSTANORDNENDES ARZNEIMITTELNANOKONJUGAT[2019/13]
English:TUMOR CELL-SPECIFIC RESPONSIVE SELF-ASSEMBLING DRUG NANOCONJUGATE[2019/13]
French:NANOCONJUGUÉ DE MÉDICAMENT À AUTO-ASSEMBLAGE SENSIBLE SPÉCIFIQUE AUX CELLULES TUMORALES[2019/13]
Examination proceduredeletedDate on which the examining division has become responsible
18.04.2018Examination requested  [2019/13]
30.04.2019Amendment by applicant (claims and/or description)
02.10.2019Despatch of a communication from the examining division (Time limit: M04)
19.11.2019Reply to a communication from the examining division
06.04.2020Communication of intention to grant the patent
12.08.2020Fee for grant paid
12.08.2020Fee for publishing/printing paid
12.08.2020Receipt of the translation of the claim(s)
Opposition(s)24.06.2021No opposition filed within time limit [2021/35]
Fees paidRenewal fee
26.03.2020Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.03.2018
AL23.09.2020
AT23.09.2020
CY23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
MK23.09.2020
MT23.09.2020
NL23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
[2024/42]
Former [2024/23]HU28.03.2018
AL23.09.2020
AT23.09.2020
CY23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
MK23.09.2020
NL23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2023/33]HU28.03.2018
AL23.09.2020
AT23.09.2020
CY23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
NL23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2023/30]AL23.09.2020
AT23.09.2020
CY23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
NL23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2023/29]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
NL23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2022/34]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
BE31.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2022/11]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
CH31.03.2021
FR31.03.2021
LI31.03.2021
Former [2022/08]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
LU28.03.2021
FR31.03.2021
Former [2022/07]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
IE28.03.2021
Former [2021/48]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
IT23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/45]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
MC23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/37]AL23.09.2020
AT23.09.2020
CZ23.09.2020
DK23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/36]AL23.09.2020
AT23.09.2020
CZ23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SI23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/28]AL23.09.2020
AT23.09.2020
CZ23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SK23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/25]AL23.09.2020
AT23.09.2020
CZ23.09.2020
EE23.09.2020
ES23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
PL23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
IS23.01.2021
PT25.01.2021
Former [2021/23]AT23.09.2020
CZ23.09.2020
EE23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
PT25.01.2021
Former [2021/22]CZ23.09.2020
EE23.09.2020
FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
RO23.09.2020
RS23.09.2020
SE23.09.2020
SM23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
PT25.01.2021
Former [2021/21]FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
RS23.09.2020
SE23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
PT25.01.2021
Former [2021/20]FI23.09.2020
HR23.09.2020
LT23.09.2020
LV23.09.2020
RS23.09.2020
SE23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
Former [2021/10]FI23.09.2020
HR23.09.2020
LV23.09.2020
RS23.09.2020
SE23.09.2020
BG23.12.2020
NO23.12.2020
GR24.12.2020
Former [2021/08]FI23.09.2020
SE23.09.2020
BG23.12.2020
NO23.12.2020
Former [2021/07]FI23.09.2020
NO23.12.2020
Documents cited:Search[Y]WO2004046169  (UNIV JOHNS HOPKINS [US], et al) [Y] 1-12 * figure 3; example 6 *;
 [Y]  - Samuel Janssen ET AL, "Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer", Molecular Cancer Therapeutics, United States, (20041101), page 1439, URL: http://mct.aacrjournals.org/content/3/11/1439.short, XP055513754 [Y] 1-12 * whole document, in particular abstract, figure 4, table 3, page 1448, right-hand column, lines 16-18 *
 [Y]  - WANG MA ET AL, "Synergistic antitumor activity of a self-assembling camptothecin and capecitabine hybrid prodrug for improved efficacy", JOURNAL OF CONTROLLED RELEASE, NL, (20170110), vol. 263, doi:10.1016/j.jconrel.2017.01.015, ISSN 0168-3659, pages 102 - 111, XP055448205 [Y] 1-12 * chapter 3.2;; figure 1 *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2017.01.015
 [Y]  - ZHIPENG CHEN ET AL, "Controlled release of free doxorubicin from peptide-drug conjugates by drug loading", JOURNAL OF CONTROLLED RELEASE, (20141001), vol. 191, doi:10.1016/j.jconrel.2014.05.051, ISSN 0168-3659, pages 123 - 130, XP055176659 [Y] 1-12 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2014.05.051
by applicantKR20030096356
    - MERRIFIELD, J. Amer. Chem. Soc., (19630000), vol. 85, pages 2149 - 54
    - STEWART et al., Solid Phase Peptide Synthesis, Pierce Chem. Co., (19840000), vol. 111
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.